Magic Mushrooms Head to Trial for Depression Therapy


The U.K.’s Medical Research Foundation has awarded £500,000 (about $800,000) to test psylocibin (extracted from “Magic” mushrooms) as a treatment for depression to Prof. David Nutt, who has called for an “evidence-based” approach to the dangers and medicinal value of drugs such as LSD, cannabis, and MDMA. “One of the things to change in parallel with the trial is the law,” says Prof. Nutt, “otherwise the big problem is if it works, no one will be able to prescribe it.”

Article →

Previous articleJ&J Anticipates $2.2 Billion Settlement with Justice Dept.
Next articleWill the APA Listen to the Voices of Those Harmed by Psychiatric Diagnosis?
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].


  1. Just another biopsychiatrist who believes tinkering with brains, will solve human problems. Note the desperation of biopsychiatry, when its synthesized poisons don’t work, they turn back to the future, to the 1960s.

    And note how he’s not calling for the legalization of drugs, just that psychiatrists get the right to decide who should get them and who should not.

    Anyone who wants to see the true face of Professor David Nutt needs only to read his powerpoint presentation “psychiatry under threat”:

    Report comment